Vancomycin
Kathryn Dzintars, Pharm.D., BCPS
Pediatric Dosing Author:
Alice Jenh Hsu, PharmD, BCPS, AQ-ID
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Treatment of serious or severe infections caused by susceptible strains of
MRSA
Initial therapy when MRSA is suspected
Oral vancomycin: antibiotic-associated pseudomembranous colitis caused by
C. difficile
and enterocolitis caused by
S. aureus
(including MRSA)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Bone and joint infections, including
hardware-associated infections
Pneumonia
Septicemia
Endocarditis
due to Gram-positive organisms
Skin and skin structure infections
Meningitis,
CNS shunt infections
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2023 Unbound Medicine, Inc. All rights reserved